Our Doctors

Nova Precision AI is at the forefront of Advancing Precision Medicine in Oncology

From one-size-fits-all to biomarker-driven treatments.

MEET Pioneers of

Precision Oncology Excellence

Dr. Sewanti Limaye

MD, MS (Columbia University, New York, USA)

Director – Medical & Precision Oncology,
Director - Clinical and Translational Oncology Research
Sir HN Reliance Foundation Hospital and Research Centre, Mumbai, India

Dr. Massimo Cristofanilli

Professor of Medicine, Chief of Breast Medical Oncology, Associate Director of Precision Oncology, Weill Cornell Medicine/ Meyer, Cancer Center, New York, USA

Chief Medical Officer-WIN Consortium for Personalized Cancer Therapy, Chair- Early Therapeutics and Rare Cancers Committee, Centre Associate Director, Professor Medical College of Wisconsin Milwaukee, WI USA

Dr. Balazs Halmos

MD, MS

Director of Clinical Cancer Genetics, Professor of Clinical Medicine at Einstein, Director Thoracic Medical Oncology, Montefiore Health Systems New York, New York USA

Dr. Shirish Gadgeel

Professor in the Department of Internal Medicine, Chief of Division of Hematology and Oncology, Associate Director of Patient Experience and Clinical Care, Henry Ford Cancer Institute, Detroit USA

Ken ’O’Byrne

MBBS, FRACP, FRCPA, MD

Professor, Medical Oncology Princess Alexandra Hospital, Queensland University of Technology, Translational Research Institute (TRI) Australia

Dr. Jochen H. Lorch

MD, MSc

Director Head & Neck and Thyroid Cancer Program, Northwestern University, Chicago, USA

Dr Daniel Catenacci

Gastrointestinal Medical Oncologist Chicago, IL USA

Dr. Ezra Cohen

MD, FRCPSC, FASCO

Chief, Division of Hematology-Oncology Associate Director, Translational Science, Leader of the Solid Tumor Therapeutics research program, Co-Director Precision Immunotherapy Clinic, San Diego Moores Cancer Center, University of California San Diego, CA, USA

Dr Philip Philip

MD,Ph.D,F.R.C.P

Professor of Oncology and Pharmacology, Wayne State University School of Medicine (WSU SOM), Leader of the Gastrointestinal and Neuroendocrine Multidisciplinary Team, Barbara Ann Karmanos Cancer Institute Detroit, Michigan USA

Dr. Patrick Wen

Professor of Neurology, Harvard Medical School Director, Centre for Neuro-Oncology, Dana-Farber Cancer Institute Boston, MA, USA

MEET OUR

Experts Doctor

Dr. Sewanti Limaye

Director

Director – Medical & Precision Oncology,
Director - Clinical and Translational Oncology Research
Sir HN Reliance Foundation Hospital and Research Centre, Mumbai, India

Dr. Massimo Cristofanilli

Professor of Medicine, Chief of Breast Medical Oncology, Associate Director of Precision Oncology, Weill Cornell Medicine/ Meyer, Cancer Center, New York, USA

Dr. Razelle Kurzrock

Dr. Anil K. Sood

Professor, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center Houston, Texas USA

Dr. Vivek Subbiah

Chief, Early-Phase Drug Development, Sarah Cannon research Institute, Nashville, Tennesee, USA

Dr Scott Kopetz

Professor, Deputy Chair for Translational Research, Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center Colon Cancer Task Force, (National cancer Institute) NCI Houston, Texas USA

Dr. Balazs Halmos

MD, MS

Director of Clinical Cancer Genetics, Professor of Clinical Medicine at Einstein, Director Thoracic Medical Oncology, Montefiore Health Systems New York, New York USA

Dr. Shirish Gadgeel

Professor in the Department of Internal Medicine, Chief of Division of Hematology and Oncology, Associate Director of Patient Experience and Clinical Care, Henry Ford Cancer Institute, Detroit USA

Dr. Paul Hofman

MD, Ph.D.

Academic Director, Professor Laboratory of Clinical and Experimental Pathology (LPCE), Université Côte d’Azur, Louis Pasteur Hospital Nice France

Ken ’O’Byrne

MBBS, FRACP, FRCPA, MD

Professor, Medical Oncology Princess Alexandra Hospital, Queensland University of Technology, Translational Research Institute (TRI) Australia

Dr. Jochen H. Lorch

MD, MSc

Director Head & Neck and Thyroid Cancer Program, Northwestern University, Chicago, USA

Dr Giuseppe Curigliano

MD, Ph.D

Associate Professor of Medical Oncology, Director, Division of Early Drug Development at the European Institute of Oncology, University of Milano, Milano Italy

Dr Josep Llovet

MD, Ph.D

Founder and Director of the Liver Cancer Program, Icahn School of Medicine Professor of Research-ICREA in the BCLC Group, Liver Unit, IDIBAPS-Hospital Clínic of Barcelona, Professor of Medicine Mount Sinai School of Medicine New York, New York USA

Dr Daniel Catenacci

Gastrointestinal Medical Oncologist Chicago, IL USA

Dr. Ezra Cohen

MD, FRCPSC, FASCO

Dr Philip Philip

MD,Ph.D,F.R.C.P

Dr Colin Weekes

MD, Ph.D

Director, Medical Oncology Research for Pancreatic Cancer Director, Cancer Center Grand Rounds Program Mass General Cancer Centre, Boston USA

Dr. Patrick Wen

Professor of Neurology, Harvard Medical School Director, Centre for Neuro-Oncology, Dana-Farber Cancer Institute Boston, MA, USA

Dr. Richard Lee

MD, Ph.D

Clinical Co-Director, The Claire and John Bertucci Center for Genitourinary Cancers, Assistant Physician, Department of Medicine, Massachusetts General Hospital Boston, MA, USA

Dr. Swaminathan P. Iyer

Professor, Department of Lymphoma-Myeloma Division of Cancer Medicine, The University of Texas MD Anderson Cancer Centre Houston, Texas, USA

Your Partner in Health and Wellness

Phone

Email

Location

Be Our Subscribers

Follow Us

Nova Precision AI is at the forefront of Advancing Precision Medicine in Oncology

MEET Pioneers of

Precision Oncology Excellence

MEET OUR

Experts Doctor